WPRIM Management System> DCMS> Blood Research> 2021> 56> 3

Volume: 56 Issue: 3

1. Management of COVID-19-related immune thrombocytopenia by rhTPO Page:205—207
2. Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study Page:202—204
3. Development and validation of a comorbidity index for predicting survival outcomes after allogeneic stem cell transplantation in adult patients with acute leukemia: a Korean nationwide cohort study Page:184—196
4. Impact of timely BCR-ABL1 monitoring before allogeneic stem cell transplantation among patients with BCR-ABL1-positive B-acute lymphoblastic leukemia Page:175—183
5. Causes of erythrocytosis and its impact as a risk factor for thrombosis according to etiology: experience in a referral center in Mexico City Page:166—174
6. The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patients Page:156—165
7. T cell acute lymphoblastic leukemia with t(11;14)(p13;q11) and trisomy 8 Page:128—128
8. Ruxolitinib-induced extreme thrombocytosis in a COVID-19patient Page:201—202
9. Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report Page:197—207
10. New cut-off point for D-dimer in the diagnosis of pulmonary embolism during pregnancy Page:150—155
11. Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma:a single-center experience Page:134—140
12. Clinical analysis of hospitalized patients with hemophilia A:single-hemophilia treatment center experience in Korea over 10 years Page:141—149
13. Platelet count as an important prognostic factor for vaccine-induced immune thrombotic thrombocytopenia Page:129—133
14. Plasma cells in disguise: the masquerader in hematopathology Page:127—127
15. Green-blue intracytoplasmic inclusions in the bone marrow in severe COVID-19 Page:126—126
16. How to diagnose lymphoplasmacytic lymphoma without infiltration of plasmacytoid lymphocytes? Page:125—125
17. Management of COVID-19-related immune thrombocytopenia by rhTPO Page:205—207
18. Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study Page:202—204
19. Development and validation of a comorbidity index for predicting survival outcomes after allogeneic stem cell transplantation in adult patients with acute leukemia: a Korean nationwide cohort study Page:184—196
20. Impact of timely BCR-ABL1 monitoring before allogeneic stem cell transplantation among patients with BCR-ABL1-positive B-acute lymphoblastic leukemia Page:175—183
21. Causes of erythrocytosis and its impact as a risk factor for thrombosis according to etiology: experience in a referral center in Mexico City Page:166—174
22. The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patients Page:156—165
23. T cell acute lymphoblastic leukemia with t(11;14)(p13;q11) and trisomy 8 Page:128—128
24. Ruxolitinib-induced extreme thrombocytosis in a COVID-19patient Page:201—202
25. Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report Page:197—207
26. New cut-off point for D-dimer in the diagnosis of pulmonary embolism during pregnancy Page:150—155
27. Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma:a single-center experience Page:134—140
28. Clinical analysis of hospitalized patients with hemophilia A:single-hemophilia treatment center experience in Korea over 10 years Page:141—149
29. Platelet count as an important prognostic factor for vaccine-induced immune thrombotic thrombocytopenia Page:129—133
30. Plasma cells in disguise: the masquerader in hematopathology Page:127—127
31. Green-blue intracytoplasmic inclusions in the bone marrow in severe COVID-19 Page:126—126
32. How to diagnose lymphoplasmacytic lymphoma without infiltration of plasmacytoid lymphocytes? Page:125—125